Literature DB >> 9561562

Glycoprotein B of Aujeszky's disease virus: topographical epitope mapping and epitope-specific antibody response.

M M Zaripov1, O S Morenkov, B Siklodi, I Barna-Vetro, A Gyöngyösi-Horvath, I Fodor.   

Abstract

A panel of 26 monoclonal antibodies (mAbs) against glycoprotein B (gB) of Aujeszky's disease (pseudorabies) virus (ADV), a glycoprotein complex consisting of three glycoproteins, gBa, gBb, and gBc, was produced by two research groups and was used for the topographical epitope mapping of gB. An epitope map was constructed in which the identified epitopes of gB were situated in 14 topologically distinct antigenic domains; ten antigenic domains represented by 22 mAbs were localized on gBc, while four antigenic domains represented by four mAbs resided on gBb of the gB complex. All the epitopes located on gBc appeared to be conformation-dependent, whereas all the epitopes on gBb were conformation-independent. The identified epitopes of gB were conserved among laboratory, vaccine and field ADV strains. Conformation-dependent epitopes were shown to contribute largely to the overall antibody response to gB in naturally infected swine and immunized mice. Moreover, it was found that most of the infected animals responded relatively weakly to the identified conformation-independent epitopes of gB, while a group of immunodominant epitopes that induced a strong antibody response was represented exclusively by conformation-dependent epitopes from different antigenic domains. The results clearly demonstrated that conformation-dependent epitopes of gBc play a crucial role in inducing the humoral immune response to gB of ADV during the natural infection of swine and immunization of mice. The application of mAbs of our panel as research and diagnostic tools is discussed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9561562     DOI: 10.1016/s0923-2516(97)86898-7

Source DB:  PubMed          Journal:  Res Virol        ISSN: 0923-2516


  5 in total

1.  Identification of Genogroup I and Genogroup II broadly reactive epitopes on the norovirus capsid.

Authors:  Tracy Dewese Parker; Noritoshi Kitamoto; Tomoyuki Tanaka; Anne M Hutson; Mary K Estes
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

2.  Polarization of protective immunity induced by replication-incompetent adenovirus expressing glycoproteins of pseudorabies virus.

Authors:  Young Woo Han; Abi G Aleyas; Junu A George; Seon Ju Kim; Hye Kyung Kim; Hyun A Yoon; Dong Jin Yoo; Seong Ho Kang; Koanhoi Kim; Seong Kug Eo
Journal:  Exp Mol Med       Date:  2008-12-31       Impact factor: 8.718

3.  Two classes of protective antibodies against Pseudorabies virus variant glycoprotein B: Implications for vaccine design.

Authors:  Xiangdong Li; Fanli Yang; Xule Hu; Feifei Tan; Jianxun Qi; Ruchao Peng; Min Wang; Yan Chai; Liying Hao; Junhua Deng; Chenyu Bai; Juan Wang; Hao Song; Shuguang Tan; Guangwen Lu; George F Gao; Yi Shi; Kegong Tian
Journal:  PLoS Pathog       Date:  2017-12-20       Impact factor: 6.823

4.  A 2,5-Dihydroxybenzoic Acid-Gelatin Conjugate: The Synthesis, Antiviral Activity and Mechanism of Antiviral Action Against Two Alphaherpesviruses.

Authors:  Alexander Lisov; Veronika Vrublevskaya; Zoy Lisova; Alexey Leontievsky; Oleg Morenkov
Journal:  Viruses       Date:  2015-10-15       Impact factor: 5.048

5.  Whole-Genome Sequence Analysis of Pseudorabies Virus Clinical Isolates from Pigs in China between 2012 and 2017 in China.

Authors:  Ruiming Hu; Leyi Wang; Qingyun Liu; Lin Hua; Xi Huang; Yue Zhang; Jie Fan; Hongjian Chen; Wenbo Song; Wan Liang; Nengshui Ding; Zuohua Li; Zhen Ding; Xibiao Tang; Zhong Peng; Bin Wu
Journal:  Viruses       Date:  2021-07-08       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.